Genetic rearrangements of variable di-residue (RVD)-containing repeat arrays in a baculoviral TALEN system

Molecular Therapy Methods and Clinical Development

Volumn 1, Issue , 2014, Pages 14050-

  Lau, Cia Hin ^a   Zhu, Haibao ^a   Tay, Johan Chin Kang ^a   Li, Zhendong ^a   Tay, Felix Chang ^a   Chen, Can ^a   Tan, Wee Kiat ^a   Du, Shouhui ^a   Sia, Vic Ki ^a   Phang, Rui Zhe ^a   Tang, Shin Yi ^a   Yang, Chiyun ^a   Chi, Zhixia ^a   Liang, Chieh Ching ^a   Ning, Er ^a   Wang, Shu ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BACMID; BACULOVIRUS VECTOR; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE;

AAVS1 GENE; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; DNA SEQUENCE; DNA STRAND; GENE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENE TARGETING; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; SEQUENCE ANALYSIS; VIRUS RECOMBINANT;

EID: 85015705137     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2014.50     Document Type: Article

References (55)

1. 1 Urnov, FD, Miller, JC, Lee, YL, Beausejour, CM, Rock, JM, Augustus, S, et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435 (2005), 646–651.
2. 2 Hockemeyer, D, Soldner, F, Beard, C, Gao, Q, Mitalipova, M, DeKelver, RC, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 27 (2009), 851–857.
3. 3 Bedell, VM, Wang, Y, Campbell, JM, Poshusta, TL, Starker, CG, Krug, RG 2nd, et al. In vivo genome editing using a high-efficiency TALEN system. Nature 491 (2012), 114–118.
4. 4 Kim, Y, Kweon, J, Kim, A, Chon, JK, Yoo, JY, Kim, HJ, et al. A library of TAL effector nucleases spanning the human genome. Nat Biotechnol 31 (2013), 251–258.
5. 5 Mali, P, Yang, L, Esvelt, KM, Aach, J, Guell, M, DiCarlo, JE, et al. RNA-guided human genome engineering via Cas9. Science 339 (2013), 823–826.
6. 6 Cong, L, Ran, FA, Cox, D, Lin, S, Barretto, R, Habib, N, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339 (2013), 819–823.
7. 7 Li, L, Krymskaya, L, Wang, J, Henley, J, Rao, A, Cao, LF, et al. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases. Mol Ther 21 (2013), 1259–1269.
8. 8 Maier, DA, Brennan, AL, Jiang, S, Binder-Scholl, GK, Lee, G, Plesa, G, et al. Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5. Hum Gene Ther 24 (2013), 245–258.
9. 9 Händel, EM, Gellhaus, K, Khan, K, Bednarski, C, Cornu, TI, Müller-Lerch, F, et al. Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors. Hum Gene Ther 23 (2012), 321–329.
10. 10 Lei, Y, Lee, CL, Joo, KI, Zarzar, J, Liu, Y, Dai, B, et al. Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases. Mol Ther 19 (2011), 942–950.
11. 11 Tay, FC, Tan, WK, Goh, SL, Ramachandra, CJ, Lau, CH, Zhu, H, et al. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells. J Gene Med 15 (2013), 384–395.
12. 12 Phang, RZ, Tay, FC, Goh, SL, Lau, CH, Zhu, H, Tan, WK, et al. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells. Stem Cells Transl Med 2 (2013), 935–945.
13. 13 Joglekar, AV, Hollis, RP, Kuftinec, G, Senadheera, S, Chan, R, Kohn, DB, Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus. Mol Ther 21 (2013), 1705–1717.
14. 14 Lombardo, A, Genovese, P, Beausejour, CM, Colleoni, S, Lee, YL, Kim, KA, et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25 (2007), 1298–1306.
15. 15 Malina, A, Mills, JR, Cencic, R, Yan, Y, Fraser, J, Schippers, LM, et al. Repurposing CRISPR/Cas9 for in situ functional assays. Genes Dev 27 (2013), 2602–2614.
16. 16 Koike-Yusa, H, Li, Y, Tan, EP, Velasco-Herrera, Mdel C, Yusa, K, Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 32 (2014), 267–273.
17. 17 Shalem, O, Sanjana, NE, Hartenian, E, Shi, X, Scott, DA, Mikkelsen, TS, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343 (2014), 84–87.
18. 18 Wang, T, Wei, JJ, Sabatini, DM, Lander, ES, Genetic screens in human cells using the CRISPR-Cas9 system. Science 343 (2014), 80–84.
19. 19 Miller, JC, Tan, S, Qiao, G, Barlow, KA, Wang, J, Xia, DF, et al. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29 (2011), 143–148.
20. 20 Mak, AN, Bradley, P, Cernadas, RA, Bogdanove, AJ, Stoddard, BL, The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 335 (2012), 716–719.
21. 21 Deng, D, Yan, C, Pan, X, Mahfouz, M, Wang, J, Zhu, JK, et al. Structural basis for sequence-specific recognition of DNA by TAL effectors. Science 335 (2012), 720–723.
22. 22 Bergmann, T, Schulz, E, Ehrhardt, A, Progress and problems with viral vectors for delivery of Talens. J Mol Genet Med, 8, 2014, 096.
23. 23 Holkers, M, Maggio, I, Liu, J, Janssen, JM, Miselli, F, Mussolino, C, et al. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res, 41, 2013, e63.
24. 24 Holkers, M, Cathomen, T, Gonçalves, MA, Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells. Methods 69 (2014), 179–187.
25. 25 Zhang, Z, Zhang, S, Huang, X, Orwig, KE, Sheng, Y, Rapid assembly of customized TALENs into multiple delivery systems. PLoS ONE, 8, 2013, e80281.
26. 26 Yang, L, Guell, M, Byrne, S, Yang, JL, De Los Angeles, A, Mali, P, et al. Optimization of scarless human stem cell genome editing. Nucleic Acids Res 41 (2013), 9049–9061.
27. 27 Konermann, S, Brigham, MD, Trevino, AE, Hsu, PD, Heidenreich, M, Cong, L, et al. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500 (2013), 472–476.
28. 28 Zhu, H, Lau, CH, Goh, SL, Liang, Q, Chen, C, Du, S, et al. Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in human-induced pluripotent stem cells. Nucleic Acids Res, 41, 2013, e180.
29. 29 Ramachandra, CJ, Shahbazi, M, Kwang, TW, Choudhury, Y, Bak, XY, Yang, J, et al. Efficient recombinase-mediated cassette exchange at the AAVS1 locus in human embryonic stem cells using baculoviral vectors. Nucleic Acids Res, 39, 2011, e107.
30. 30 Zeng, J, Du, J, Zhao, Y, Palanisamy, N, Wang, S, Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 25 (2007), 1055–1061.
31. 31 Chen, GY, Hwang, SM, Su, HJ, Kuo, CY, Luo, WY, Lo, KW, et al. Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction. J Virol 86 (2012), 8041–8049.
32. 32 Airenne, KJ, Hu, YC, Kost, TA, Smith, RH, Kotin, RM, Ono, C, et al. Baculovirus: an insect-derived vector for diverse gene transfer applications. Mol Ther 21 (2013), 739–749.
33. 33 Zeng, J, Du, J, Lin, J, Bak, XY, Wu, C, Wang, S, High-efficiency transient transduction of human embryonic stem cell-derived neurons with baculoviral vectors. Mol Ther 17 (2009), 1585–1593.
34. 34 Walsh, PS, Erlich, HA, Higuchi, R, Preferential PCR amplification of alleles: mechanisms and solutions. PCR Methods Appl 1 (1992), 241–250.
35. 35 Olejniczak, M, Krzyzosiak, WJ, Genotyping of simple sequence repeats–factors implicated in shadow band generation revisited. Electrophoresis 27 (2006), 3724–3734.
36. 36 Viguera, E, Canceill, D, Ehrlich, SD, In vitro replication slippage by DNA polymerases from thermophilic organisms. J Mol Biol 312 (2001), 323–333.
37. 37 Godiska, R, Mead, D, Dhodda, V, Wu, C, Hochstein, R, Karsi, A, et al. Linear plasmid vector for cloning of repetitive or unstable sequences in Escherichia coli. Nucleic Acids Res, 38, 2010, e88.
38. 38 Pierce, JC, Kong, D, Masker, W, The effect of the length of direct repeats and the presence of palindromes on deletion between directly repeated DNA sequences in bacteriophage T7. Nucleic Acids Res 19 (1991), 3901–3905.
39. 39 Luckow, VA, Lee, SC, Barry, GF, Olins, PO, Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J Virol 67 (1993), 4566–4579.
40. 40 Martin, DW, Weber, PC, DNA replication promotes high-frequency homologous recombination during Autographa californica multiple nuclear polyhedrosis virus infection. Virology 232 (1997), 300–309.
41. 41 Kamita, SG, Maeda, S, Hammock, BD, High-frequency homologous recombination between baculoviruses involves DNA replication. J Virol 77 (2003), 13053–13061.
42. 42 Crouch, EA, Passarelli, AL, Genetic requirements for homologous recombination in Autographa californica nucleopolyhedrovirus. J Virol 76 (2002), 9323–9334.
43. 43 Hajós, JP, Pijnenburg, J, Usmany, M, Zuidema, D, Závodszky, P, Vlak, JM, High frequency recombination between homologous baculoviruses in cell culture. Arch Virol 145 (2000), 159–164.
44. 44 Feschenko, VV, Lovett, ST, Slipped misalignment mechanisms of deletion formation: analysis of deletion endpoints. J Mol Biol 276 (1998), 559–569.
45. 45 Giri, L, Feiss, MG, Bonning, BC, Murhammer, DW, Production of baculovirus defective interfering particles during serial passage is delayed by removing transposon target sites in fp25k. J Gen Virol 93:Pt 2 (2012), 389–399.
46. 46 Thompson, KA, Yin, J, Population dynamics of an RNA virus and its defective interfering particles in passage cultures. Virol J, 7, 2010, 257.
47. 47 Boch, J, Scholze, H, Schornack, S, Landgraf, A, Hahn, S, Kay, S, et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326 (2009), 1509–1512.
48. 48 Yan, W, Smith, C, Cheng, L, Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing. Sci Rep, 3, 2013, 2376.
49. 49 Boissel, S, Jarjour, J, Astrakhan, A, Adey, A, Gouble, A, Duchateau, P, et al. megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering. Nucleic Acids Res 42 (2014), 2591–2601.
50. 50 Abe, T, Matsuura, Y, Host innate immune responses induced by baculovirus in mammals. Curr Gene Ther 10 (2010), 226–231.
51. 51 Wang, S, Balasundaram, G, Potential cancer gene therapy by baculoviral transduction. Curr Gene Ther 10 (2010), 214–225.
52. 52 Ono, C, Ninomiya, A, Yamamoto, S, Abe, T, Wen, X, Fukuhara, T, et al. Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells. J Virol 88 (2014), 2157–2167.
53. 53 Luo, WY, Lin, SY, Lo, KW, Lu, CH, Hung, CL, Chen, CY, et al. Adaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo. J Virol 87 (2013), 4965–4973.
54. 54 Chuang, CK, Wong, TH, Hwang, SM, Chang, YH, Chen, GY, Chiu, YC, et al. Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. Mol Ther 17 (2009), 889–896.
55. 55 Sakuma, T, Hosoi, S, Woltjen, K, Suzuki, K, Kashiwagi, K, Wada, H, et al. Efficient TALEN construction and evaluation methods for human cell and animal applications. Genes Cells 18 (2013), 315–326.